Andrew Regan - 03 Jun 2025 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Andrew Regan
Issuer symbol: CDT
Transactions as of: 03 Jun 2025
Transactions value $: $500,001
Form type: 4
Filing time: 13 Jun 2025, 07:17:07 UTC
Previous filing: 19 Sep 2024
Next filing: 22 Sep 2025
SEC: View on sec.gov

Reporting Owners (2)

Name	Relationship	Address	Signature	Signature date	CIK
Regan Andrew	Chief Executive Officer, Director, 10%+ Owner	4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES	/s/ Andrew Regan	13 Jun 2025	0001991325
Corvus Capital Ltd.	10%+ Owner	4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES	CORVUS CAPITAL LTD. By: /s/ Andrew Regan Name: Andrew Regan Title: Chief Executive Officer	13 Jun 2025	0001990829

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDT	Common Stock	Award	$500K	+155K		$3.23	155K	03 Jun 2025	See Footnote	F1, F2
holding	CDT	Common Stock						20K	03 Jun 2025	See Footnote	F3, F4, F6
holding	CDT	Common Stock						118	03 Jun 2025	See Footnote	F3, F5, F6
holding	CDT	Common Stock						44	03 Jun 2025	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Based on the closing price per share of the Issuer's common stock, par value $0.0001 ("Common Stock"), on June 3, 2025.
F2	These shares of Common Stock are owned of record by Manoira Corporation ("Manoira"). On June 3, 2025, the Issuer issued 154,799 shares of Common Stock to Manoira pursuant to that certain joint development agreement (the "Joint Development Agreement") by and between the Issuer and Manoira, representing an up-front consideration of $500,000.
F3	On January 24, 2025, the Issuer effected a 1-for-100 reverse stock split (the "January Reverse Split") and, on May 15, 2025, subsequently effected a 1-for-15 reverse stock split (together with the January 2025 Reverse Split, the "Reverse Splits"). The number of shares of Common Stock reported has been adjusted to give effect to the Reverse Splits.
F4	These shares of Common Stock are owned of record by Corvus Capital Limited ("Corvus").
F5	These shares of Common Stock are owned of record by Algo Holdings, Inc. ("Algo").
F6	Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Andrew Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership except to the extent of its or his pecuniary interest therein.